Malaria Vaccine: A Future Hope to Curtail the Global Malaria Burden

It has been estimated that nearly half of the world's population is at the risk of contracting malaria with sub Saharan Africa being the most risky area. The existing frontline malaria control interventions are not only expensive but also become ineffective owing to the emergence of insecticide and drug resistance. It calls for an innovative approach in terms of potential and reliable vaccine as an additional tool. Over centuries, the public health experts have been actively engaged to formulate a safe, affordable and potential malaria vaccine and accordingly a notable achievement has also been attained. However, many challenges are required to be flagged immediately and effectively to devise an ideal prophylactic malaria vaccine. Therefore, the global community has to remain waiting quite a few more years to build a wannabe malaria-free world in the near future.

• Publication year

  2014

• Venue

  International Journal of Preventive Medicine

• Publication date

  2014-05-01

• Fields of study

  Medicine, Environmental Science

• Identifiers
  PMID 24932383PMCID 4050672
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Global Malaria Burden: Socialomics Implications

  2016cited by this paper
• First Results of Phase 3 Trial of RTS,S/AS01 Malaria Vaccine in African Children

  2013cited by this paper
• Malaria vaccines and the new malaria agenda.

  2011cited by this paper
• Safety and efficacy of the RTS,S/AS01E candidate malaria vaccine given with expanded-programme-on-immunisation vaccines: 19 month follow-up of a randomised, open-label, phase 2 trial.

  2011cited by this paper
• Comparative efficacy of pre-erythrocytic whole organism vaccine strategies against the malaria parasite.

  2011cited by this paper
• Vector control: a cornerstone in the malaria elimination campaign.

  2011cited by this paper
• A Research Agenda for Malaria Eradication: Vaccines

  2011cited by this paper
• First results of phase 3 trial of RTS,S/AS01 malaria vaccine in African children.

  2011cited by this paper
• World malaria report 2011

  2011cited by this paper
• Artemisinin resistance--the clock is ticking.

  2010cited by this paper
• Evaluation of the safety and immunogenicity of the RTS,S/AS01E malaria candidate vaccine when integrated in the expanded program of immunization.

  2010cited by this paper
• The expanding vaccine development pipeline, 1995-2008.

  2010cited by this paper
• Experimental human challenge infections can accelerate clinical malaria vaccine development

  2010influential reference
• Laboratory evaluation of dimethyl phthalate treated wristbands against three predominant mosquito (Diptera: Culicidae) vectors of disease.

  2010cited by this paper
• Larvicidal activity of Cymbopogon citratus (DC) Stapf. and Croton macrostachyus Del. against Anopheles arabiensis Patton, a potent malaria vector.

  2010cited by this paper
• Knowledge and practice concerning malaria, insecticide-treated net (ITN) utilization and antimalarial treatment among pregnant women attending specialist antenatal clinics

  2010cited by this paper
• Identification of Plasmodium malariae, a Human Malaria Parasite, in Imported Chimpanzees

  2009cited by this paper
• The potential role of vaccines in the elimination of falciparum malaria and the eventual eradication of malaria.

  2009cited by this paper
• Development of the RTS,S/AS malaria candidate vaccine.

  2009cited by this paper
• Malaria Vaccines: Where Next?

  2009cited by this paper
• Efficacy of RTS,S/AS01E vaccine against malaria in children 5 to 17 months of age.

  2008cited by this paper
• Patenting malarial vaccine.

  2008cited by this paper
• Malaria vaccine: a current perspective.

  2008influential reference
• Safety and immunogenicity of RTS,S/AS02D malaria vaccine in infants.

  2008cited by this paper
• WITHDRAWN: Vaccines for preventing malaria.

  2007cited by this paper
• Direct Microscopic Quantification of Dynamics of Plasmodium berghei Sporozoite Transmission from Mosquitoes to Mice

  2007cited by this paper
• Pre-erythrocytic stage malaria vaccines: time for a change in path.

  2007cited by this paper
• Safety of the RTS,S/AS02D candidate malaria vaccine in infants living in a highly endemic area of Mozambique: a double blind randomised controlled phase I/IIb trial.

  2007cited by this paper
• Construction and evaluation of a multistage combination vaccine against malaria.

  2007cited by this paper
• Vaccines for preventing malaria (pre-erythrocytic).

  2006influential reference
• Malaria vaccine development: progress and challenges.

  2006cited by this paper
• Pre-erythrocytic malaria vaccines: towards greater efficacy

  2006cited by this paper
• Towards an RTS,S-Based, Multi-Stage, Multi- Antigen Vaccine Against Falciparum Malaria: Progress at the Walter Reed Army Institute of Research

  2005cited by this paper
• Towards an RTS,S-based, multi-stage, multi-antigen vaccine against falciparum malaria: progress at the Walter Reed Army Institute of Research.

  2005cited by this paper
• What are malaria parasites?

  2005cited by this paper
• Clinical outcome of experimental human malaria induced by Plasmodium falciparum-infected mosquitoes.

  2005cited by this paper
• A large focus of naturally acquired Plasmodium knowlesi infections in human beings.

  2004cited by this paper
• Incidence of severe Plasmodium falciparum malaria as a primary endpoint for vaccine efficacy trials in Bandiagara, Mali.

  2004cited by this paper
• Efficacy of the RTS,S/AS02A vaccine against Plasmodium falciparum infection and disease in young African children: randomised controlled trial.

  2004cited by this paper
• LINKAGE BETWEEN NUCLEAR AND MITOCHONDRIAL DNA SEQUENCES IN AVIAN MALARIA PARASITES: MULTIPLE CASES OF CRYPTIC SPECIATION?

  2004cited by this paper
• Testing vaccines in human experimental malaria: statistical analysis of parasitemia measured by a quantitative real-time polymerase chain reaction.

  2004cited by this paper
• Imaging movement of malaria parasites during transmission by Anopheles mosquitoes

  2004cited by this paper
• Vaccines for preventing malaria.

  2003cited by this paper
• Vaccines for preventing malaria.

  2003cited by this paper
• Progress and challenges for malaria vaccines

  2002cited by this paper
• A recombinant blood-stage malaria vaccine reduces Plasmodium falciparum density and exerts selective pressure on parasite populations in a phase 1-2b trial in Papua New Guinea.

  2002cited by this paper
• The economic and social burden of malaria

  2002cited by this paper
• Transmission blocking malaria vaccines.

  2001cited by this paper
• The neglected burden of Plasmodium vivax malaria.

  2001influential reference
• Malaria transmission-blocking vaccines—how can their development be supported?

  2000influential reference
• Minimal efficacy requirements for malarial vaccines to significantly lower transmission in epidemic or seasonal malaria.

  1993cited by this paper
• Quantitation of malaria sporozoites transmitted in vitro during salivation by wild Afrotropical Anopheles

  1991cited by this paper
• Naturally acquired immunity to Plasmodium falciparum.

  1991cited by this paper
• Feeding behaviour and sporozoite ejection by infected Anopheles stephensi.

  1991cited by this paper
• Naturally acquired immunity to Plasmodium falciparum

  1991cited by this paper
• Naturally acquired immunity to Plasmodium falciparum.

  1991cited by this paper
• An estimation of the number of malaria sporozoites ejected by a feeding mosquito.

  1990cited by this paper
• Immunization of rhesus monkeys against Plasmodium knowlesi malaria.

  1965cited by this paper
• Early activity in sporozoite-induced Plasmodium falciparum infections.

  1959cited by this paper
• THE WORLD HEALTH ORGANIZATION

  1954cited by this paper
• Immunization of monkeys against malaria by means of killed parasites with adjuvants.

  1948cited by this paper

• Underlining the Mechanistic Insights In Managing The Malaria Through Novel Nano-therapeutics and Herbal Drug Technology Approach:An Updated Review

  2025cites this paper
• Potential of Malaria Vaccine in Eliminating Malaria: a Systematic Literature Review

  2024cites this paper
• DESIGNING mRNA BASED MULTISTAGE VACCINE FOR MALARIA

  2023cites this paper
• Malaria: A backyard enemy

  2023cites this paper
• Current challenges and nanotechnology-based pharmaceutical strategies for the treatment and control of malaria

  2022cites this paper
• Optimal control of a two-group malaria transmission model with vaccination

  2022cites this paper
• Process development and preclinical evaluation of a major Plasmodium falciparum blood stage vaccine candidate, Cysteine-Rich Protective Antigen (CyRPA)

  2022cites this paper
• History Of Malaria

  2022cites this paper
• Dramatic transcriptomic differences in Macaca mulatta and Macaca fascicularis with Plasmodium knowlesi infections

  2021cites this paper
• The Implications of Zinc Therapy in Combating the COVID-19 Global Pandemic

  2021cites this paper
• Eradication of Malaria: Present Situations and New Strategies

  2021cites this paper
• Hydroxychloroquine and Covid-19: A Cellular and Molecular Biology Based Update

  2020cites this paper
• A SYSTEMATIC REVIEW ON CLINICAL & STRUCTURAL EFFICACY OF HYDROXYCHLOROQUINE IN TREATMENT OF COVID-19 & RHEUMATOID ARTHRITIS

  2020cites this paper
• Malaria | Encyclopedia

  2020cites this paper
• Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology

  2020cites this paper
• Design, synthesis, and characterization of novel substituted 1,2,4-oxadiazole and their biological broadcast

  2020cites this paper
• Receptores del hospedero implicados en la invasión del merozoito de Plasmodium falciparum: Revisión

  2019cites this paper
• Malaria: The Past and the Present

  2019cites this paper
• Deteksi Resistensi Parasit terhadap Obat Sulfadoksin-Pirimetamin dan Genotyping msp-2 sebagai Dasar Pengembangan Vaksin Malaria dengan

  2019cites this paper
• Investigating calcium channel blockers as antimalarials

  2018cites this paper
• Seasonal variations in Plasmodium falciparum genetic diversity and multiplicity of infection in asymptomatic children living in southern Ghana

  2018cites this paper
• Antimalarial activity and safety assessment of Flueggea virosa leaves and its major constituent with special emphasis on their mode of action.

  2017cites this paper
• Whole-Killed Blood-Stage Vaccine-Induced Immunity Suppresses the Development of Malaria Parasites in Mosquitoes

  2017cites this paper
• The Open University ’ s repository of research publications and other research outputs Spiroindolone NITD 609 is a novel antimalarial drug that targets the P-type ATPase PfATP

  2017cites this paper
• Antimalarial Drugs as Immune Modulators: New Mechanisms for Old Drugs.

  2017cites this paper
• Backbone and side-chain resonance assignments of Plasmodium falciparum SUMO

  2017cites this paper
• Differential T‐cell responses to a chimeric Plasmodium falciparum antigen; UB05‐09, correlates with acquired immunity to malaria

  2016cites this paper
• Analysis of the immune response of a new malaria vaccine based on the modification of cryptic epitopes

  2016cites this paper
• Spiroindolone NITD609 is a novel antimalarial drug that targets the P-type ATPase PfATP4.

  2016cites this paper
• Malaria: Control, Elimination, and Eradication

  2016cites this paper
• Backbone and side-chain resonance assignments of Plasmodium falciparum SUMO

  2016cites this paper
• In-Vivo Anti-Plasmodium Activity of Crude Extracts and Solvent Fractions of Strychnos Mitis Leaves in Plasmodium Berghei Infected Mice

  2015cites this paper
• Allelic variation and multigenic metabolic activity of cytochrome P450s confer insecticide resistance in field populations of anopheles funestus s.s., a major malaria vector in Africa

  2015cites this paper
• Molecular signatures for vaccine development.

  2015cites this paper
• Inhibition of Plasmodium berghei Development in Mosquitoes by Effector Proteins Secreted from Asaia sp. Bacteria Using a Novel Native Secretion Signal

  2015cites this paper
• Malaria and blood transfusion: major issues of blood safety in malaria-endemic countries and strategies for mitigating the risk of Plasmodium parasites

  2015influential citation
• Investigation of Novel Antimalarial Agents and Novel Target Identification Approaches

  2015cites this paper
• The counterfeit anti-malarial is a crime against humanity: a systematic review of the scientific evidence

  2014influential citation
• Microsoft Word-Zhangetal_manuscript_withfigures

  2014cites this paper
• Papaya: A gifted nutraceutical plant - a critical review of recent human health research

  2014cites this paper
• Spiroindolone NITD 609 is a novel antimalarial that targets the P-type ATPase PfATP 4

  2014cites this paper
• Structural and Inhibitory Effects of Hinge Loop Mutagenesis in Serpin-2 from the Malaria Vector Anopheles gambiae*

  2014cites this paper